Wejdan Bagais joins Ethics Talk to discuss her article, coauthored with Matt Christian: “Which Data Analytics Tool Should We Use to Evaluate Risk in Upstream Drug Supply Chains?”
Dr Geoff Hollett joins Ethics Talk to discuss his article, coauthored with Dr Jennie B. Jarrett: “How Should Resources From National Stockpiles Be Managed?”
Hilary Daniel joins Ethics Talk to discuss her article, coauthored with Courtney Perlino and Dr Amy B. Cadwallader: “Which Drugs Should Be on the Essential Medicines List?”
Ruth M. Farrell, MD, MA, Holly Pederson, MD, and Shilpa Padia, MD
Though they claim to, direct-to-consumer genetic tests may not correctly identify an individual's ancestral background, and thus may overstate or understate one's risk for heritable disease.
Elderly persons should not be excluded from participation in clinical trials for cardiovascular drugs since that population comprises the largest number of patients with cardiovascular disease.